Page last updated: 2024-08-16

probenecid and rolipram

probenecid has been researched along with rolipram in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Baldi, A; Bianciotti, LG; Copsel, S; Davio, C; Diez, F; Garcia, C; Russel, FG; Shayo, C; Vermeulem, M1
Ding, HF; Dong, Z; Fang, D; Huang, S; Jing, Q; Li, Y; Su, SB; Wang, W; Zhu, JY1

Other Studies

4 other study(ies) available for probenecid and rolipram

ArticleYear
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Multidrug resistance protein 4 (MRP4/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation.
    The Journal of biological chemistry, 2011, Mar-04, Volume: 286, Issue:9

    Topics: Cell Differentiation; Cell Division; Cyclic AMP; Drug Design; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Multidrug Resistance-Associated Proteins; Phosphodiesterase 4 Inhibitors; Probenecid; RNA, Small Interfering; Rolipram; Signal Transduction; Thiazoles; U937 Cells

2011
Triple negative breast cancer development can be selectively suppressed by sustaining an elevated level of cellular cyclic AMP through simultaneously blocking its efflux and decomposition.
    Oncotarget, 2016, Dec-27, Volume: 7, Issue:52

    Topics: Animals; Cell Line, Tumor; Colforsin; Computational Biology; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Female; Humans; Mice; Mice, Inbred BALB C; Multidrug Resistance-Associated Proteins; Probenecid; Rolipram; Triple Negative Breast Neoplasms

2016